Back to top

stock-price-movement: Archive

Zacks Equity Research

Gain Therapeutics (GANX) Upgraded to Buy: Here's What You Should Know

Gain Therapeutics (GANX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

GANXPositive Net Change

Zacks Equity Research

Okeanis Eco Tankers Corp. (ECO) Upgraded to Strong Buy: Here's Why

Okeanis Eco Tankers Corp. (ECO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ECOPositive Net Change

Zacks Equity Research

Safety Insurance (SAFT) Upgraded to Buy: What Does It Mean for the Stock?

Safety Insurance (SAFT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SAFTNegative Net Change

Zacks Equity Research

All You Need to Know About Amphenol (APH) Rating Upgrade to Strong Buy

Amphenol (APH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

APHPositive Net Change

Zacks Equity Research

Alto Neuroscience, Inc. (ANRO) Upgraded to Buy: Here's What You Should Know

Alto Neuroscience, Inc. (ANRO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ANRONegative Net Change

Zacks Equity Research

CAE (CAE) Upgraded to Strong Buy: Here's What You Should Know

CAE (CAE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CAENegative Net Change

Zacks Equity Research

KLA (KLAC) Upgraded to Strong Buy: Here's What You Should Know

KLA (KLAC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

KLACPositive Net Change

Zacks Equity Research

Quest Resource (QRHC) Upgraded to Buy: Here's What You Should Know

Quest Resource (QRHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

QRHCPositive Net Change

Zacks Equity Research

All You Need to Know About Clear Secure (YOU) Rating Upgrade to Buy

Clear Secure (YOU) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

YOUNegative Net Change

Zacks Equity Research

Here's Why Pacific Biosciences (PACB) Is a Great 'Buy the Bottom' Stock Now

Pacific Biosciences (PACB) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

PACBNegative Net Change